Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 18-001877
NCT ID: NCT03375489
Sponsor Protocol Number: PCRC 17-11
About this study
This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria - Patient:
- Diagnosed with advanced NSCLC being treated with non-curative intent, and informed of advanced disease within the prior 8-12 weeks.
- Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed >50% of the day).
- The ability to read and respond to questions in English or Spanish.
- Lives in a state where their institutions’ PC clinicians are licensed to practice.
- Receiving primary cancer care at one of the participating sites.
- Age > 18 years.
Inclusion Criteria - Caregiver:
- Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week.
- The ability to read and respond to questions in English or Spanish.
- Age ≥ or 18 years.
Exclusion Criteria - Patient:
- Already receiving PC or hospice services.
- Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.
Exclusion Criteria - Caregiver:
- Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
Mayo Clinic Location |
Status |
Contact |
Rochester, Minn.
Mayo Clinic principal investigator Konstantinos Leventakos, M.D., Ph.D. |
Closed for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
More information
Publications
Publications are currently not available